                         SEQUENCE LISTING

<110>  The Trustees of Columbia University in the City of New York
 
<120>  Antivirals Against Measles Virus

<130>  44010.070WO-PCT/CU21242

<150>  63/177,224
<151>  2021-04-20

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH sequence

<400>  1

Asp Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Ser Leu Ser Leu Thr Cys Thr Val Ser Gly Tyr Ser Ile Thr Ser Asp 
            20                  25                  30          


Tyr Ala Trp Asn Trp Ile Arg Gln Phe Pro Gly Asn Lys Leu Glu Trp 
        35                  40                  45              


Met Gly Tyr Ile Ser Tyr Thr Leu Thr Thr Gly Tyr Asn Pro Ser Leu 
    50                  55                  60                  


Lys Ser Arg Ile Ser Ile Thr Arg Asp Ser Ser Lys Asn Gln Phe Phe 
65                  70                  75                  80  


Leu Gln Leu Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Gly Trp Leu Leu Pro Tyr Trp Tyr Phe Asp Val Trp Gly 
            100                 105                 110         


Ala Gly Thr Thr Val Thr Val 
        115                 


<210>  2
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL sequence

<400>  2

Asp Val Gln Ile Thr Gln Ser Pro Ser Tyr Leu Ala Ala Ser Pro Gly 
1               5                   10                  15      


Glu Thr Ile Thr Ile Asn Cys Arg Ala Ser Lys Ser Ile Ser Lys Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Glu Lys Pro Gly Lys Thr Asn Glu Leu Leu Ile 
        35                  40                  45              


Tyr Ser Gly Ser Thr Leu Gln Ser Gly Ile Pro Ser Arg Phe Arg Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Met Tyr Tyr Cys Gln Gln His Asn Glu Tyr Thr Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Leu Lys Arg 
            100                 105             


<210>  3
<211>  250
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  single-chain variable fragment antibody

<400>  3

Met Asp Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser 
1               5                   10                  15      


Gln Ser Leu Ser Leu Thr Cys Thr Val Ser Gly Tyr Ser Ile Thr Ser 
            20                  25                  30          


Asp Tyr Ala Trp Asn Trp Ile Arg Gln Phe Pro Gly Asn Lys Leu Glu 
        35                  40                  45              


Trp Met Gly Tyr Ile Ser Tyr Thr Leu Thr Thr Gly Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Ile Ser Ile Thr Arg Asp Ser Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Phe Leu Gln Leu Asn Ser Val Thr Thr Glu Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ser Gly Trp Leu Leu Pro Tyr Trp Tyr Phe Asp Val Trp 
            100                 105                 110         


Gly Ala Gly Thr Thr Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly 
        115                 120                 125             


Gly Gly Ser Gly Gly Gly Gly Ser Asp Val Gln Ile Thr Gln Ser Pro 
    130                 135                 140                 


Ser Tyr Leu Ala Ala Ser Pro Gly Glu Thr Ile Thr Ile Asn Cys Arg 
145                 150                 155                 160 


Ala Ser Lys Ser Ile Ser Lys Tyr Leu Ala Trp Tyr Gln Glu Lys Pro 
                165                 170                 175     


Gly Lys Thr Asn Glu Leu Leu Ile Tyr Ser Gly Ser Thr Leu Gln Ser 
            180                 185                 190         


Gly Ile Pro Ser Arg Phe Arg Gly Ser Gly Ser Gly Thr Asp Phe Thr 
        195                 200                 205             


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Met Tyr Tyr Cys 
    210                 215                 220                 


Gln Gln His Asn Glu Tyr Thr Leu Thr Phe Gly Gly Gly Thr Lys Leu 
225                 230                 235                 240 


Glu Leu Lys Arg His His His His His His 
                245                 250 


<210>  4
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HRC4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Proline is acetylated

<220>
<221>  MISC_FEATURE
<222>  (1)..(43)
<223>  Two of this peptide is conjugated to one cholesterol molecule

<220>
<221>  MISC_FEATURE
<222>  (42)..(42)
<223>  Cysteine is modified with PEG4-bisMaleimide

<400>  4

Pro Pro Ile Ser Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gly Asn 
1               5                   10                  15      


Ala Ile Ala Lys Leu Glu Asp Ala Lys Glu Leu Leu Glu Ser Ser Asp 
            20                  25                  30          


Gln Ile Leu Arg Gly Ser Gly Ser Gly Cys 
        35                  40          


<210>  5
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VH sequence

<400>  5
gatgtgcagc ttcaggagtc gggacctggc ctggtgaaac cttctcagtc tctgtccctc       60

acctgcactg tctctggcta ctcaatcacc agtgattatg cctggaactg gatccggcag      120

tttccaggaa acaaactgga gtggatgggc tacataagct acactcttac cactggctac      180

aacccatctc tcaaaagtcg aatctctatc actcgagact catccaagaa ccagttcttc      240

ctgcagttga attctgtgac aactgaggac acagccacat attactgtgc aagatcggga      300

tggttactac cctactggta tttcgatgtc tggggcgcag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  6
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VL sequence

<400>  6
gatgtccaga taacccagtc tccatcttat cttgctgcat ctcctggaga aaccattact       60

attaattgta gggcaagtaa gagtatcagc aaatatttag cctggtatca agagaagcct      120

gggaaaacta atgagcttct tatctactct ggatccactt tgcaatctgg aattccatca      180

aggttccgtg gcagtggatc tggtacagat ttcactctca ccatcagtag cctggagcct      240

gaagattttg caatgtatta ctgtcaacag cacaatgaat acacgctcac gttcggtggt      300

gggaccaagc tggagctgaa acgg                                             324


<210>  7
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VL sequence

<400>  7
gatgttcaga tcacacagag cccaagctac ctcgcagcat ctccaggcga gactatcact       60

atcaactgta gagcctccaa gtccatttct aagtatctgg cttggtatca ggagaagcca      120

ggtaagacca acgagctgct gatctactct ggaagcacac tccagtccgg tatcccatcc      180

agattcagag gttctggttc tggcaccgat ttcaccctga caatcagctc tctggagcct      240

gaagatttcg caatgtacta ttgtcagcag cataacgagt ataccctgac tttcggtgga      300

ggaacaaagc tcgagctgaa gcgt                                             324


<210>  8
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VH sequence

<400>  8
gacgtgcagc tccaagagag cggtcctggt ctggtgaagc cttctcaaag cctgtccctg       60

acctgtaccg tttctggcta tagcatcact tctgactacg cctggaactg gattaggcag      120

tttcctggta acaagctgga atggatgggc tacattagct acaccctgac tacaggttac      180

aatccctctc tgaagtctag gatttctatc actcgcgact cctctaagaa ccagttcttc      240

ctgcaactga atagcgtgac aacagaagat actgctacat actactgtgc aagatccggt      300

tggctgctgc cttactggta cttcgatgtg tggggtgccg gcacaaccgt gactgtcagc      360

tcc                                                                    363


